St. John’s Wort Multi-Center Trial In Mild Depression Underway
This article was originally published in The Tan Sheet
Executive Summary
A multi-center clinical trial on St. John's wort in mild depression is underway with $4 mil. in funding from three National Institutes of Health divisions, according to the National Center for Complementary and Alternative Medicine
You may also be interested in...
NIH St. John’s Wort Study In Mild Depression To Enroll 300 Participants
A total of 300 subjects suffering from minor depression are being enrolled in a four-year NIH study on the safety and efficacy of St. John's wort for treatment of the condition
St. John’s wort and drug interactions
Cancer patients, oncologists should cooperate to "develop a plan regarding which CAM practices to pursue and which to put aside altogether," NCCAM Director Stephen Straus, MD, and staff clinician Patrick Mansky, MD, advise in Aug. 21 Journal of the National Cancer Institute. "No matter how beneficial some approaches may appear to be, they are not all safe," NIH officials stress in editorial accompanying study on use of St. John's wort by cancer patients. Conducted by a Dutch research group, randomized, cross-over study of five cancer patients found anti-tumor activity of cancer drug irinotecan is negatively affected by concurrent use of St. John's wort. Findings were released at the American Association for Cancer Research annual meeting in April (1"The Tan Sheet" April 15, 2002, p. 13)...
Inconclusive St. John’s Wort Trial Prompts Queries On Study Design, Setting
The inconclusive nature of a recent study on St. John's wort suggests the current procedure for funding and designing clinical trials of botanicals may need to be reexamined, according to a letter in the July 24 Journal of the American Medical Association